Beijing Surgerii Robotics Company Limited

Beijing Surgerii Robotics Company Limited (abbreviated as Surgerii Robotics) was founded by Dr. Kai Xu, a full professor from Shanghai Jiao Tong University, based on the university’s technology transfer policy. It aims to become a global high-tech medical device enterprise dedicated to the research and development, production, and commercialization of minimally invasive laparoscopic surgical robotic systems and accessory products worldwide. Surgerii Robotics has its headquarters and a manufacturing hub in Beijing and an innovation center in Shanghai.

Surgerii Robotics has independently developed an entire spectrum of key technologies for laparoscopic surgical robots. By the end of March 2024, nearly 600 patent applications had been filed on the company’s behalf, building a comprehensive intellectual property holding. As the leading company producing newer generation laparoscopic surgical robots, Surgerii Robotics has received sizeable investments from well-known investment institutions, including the Shunwei Capital, SDIC Fund, Tianfeng Capital, Loyal Valley Capital, Hyfinity Investments, Medtronic, and Shanghai Healthcare Capital.

After nearly 20 years of dedicated research and development of key technologies for single-port robotic surgical systems, Professor Xu led Surgerii Robotics to produce a revolutionary single-port surgical robotic system. With the innovation of the “dual continuum mechanism”, the system is equipped with nitinol snake-like surgical instruments for single-port procedures. This surgical robotic system was approved by the National Medical Products Administration of China, making it the first single-port surgical robot approved for use in both urology and gynecology surgery in China. As of April 2024, Surgerii Robotics has completed clinical trials in general surgery and thoracic surgery, and more applications will be explored in the future.

Surgerii Robotics’ single-port surgical robot is an innovative technology that has various advantages, such as a wide range of motion, high payload capacity, and high reliability. It enables high surgical precision while reducing invasiveness.

Surgerii Robotics places great value on global strategies. With the mission of “Innovating surgery for better care”, Surgerii Robotics endeavors to bring designed-in-China surgical robots to the global stage. Surgerii Robotics aims to not only to become a global pioneer in technology and leader in the field of robotic surgery but to also meet the growing demand for high-quality medical treatment to improve overall human health.

Building a Comprehensive Intellectual Property Holding